Blue Owl Capital Holdings LP

New York, NY

$658m in 71 US stocks at the end of 30 June 2026. The top 10 are 79.3% of the money. It changed about 48.7% of the portfolio this quarter.

Value

$658m

Stocks

Top 10 share

79.3%

Turnover

48.7%

What changed this quarter

New

Bought for the first time this quarter.

Space Exploration TechnologiesSPCX
36.3% of the fund
Capital One FinancialCOF
3.7% of the fund
Deep FissionFISN
2.2% of the fund
Artiva BiotherapeuticsARTV
1.3% of the fund
COMPASS PathwaysCMPS
1.0% of the fund
Viridian TherapeuticsVRDN
0.7% of the fund
Cabaletta BioCABA
0.3% of the fund
Chime FinancialCHYM
0.3% of the fund
Helus PharmaHELP
<0.1% of the fund
Engene TherapeuticsENGNW
<0.1% of the fund
CelcuityCELC
<0.1% of the fund
StablecoinxUSDEW
<0.1% of the fund
Vodafone GroupVOD
<0.1% of the fund
Murano Global InvestmentsMRNO
<0.1% of the fund
Alpha Modus HoldingsAMOD
<0.1% of the fund
ZEO EnergyZEOWW
<0.1% of the fund
Livewire GroupLVWR-WS
<0.1% of the fund
Nvni Group LimitedNVNIW
<0.1% of the fund

Added

Bought more of a stock they already held.

Larimar TherapeuticsLRMR
4.2% of the fund
+29%
Dell TechnologiesDELL
2.2% of the fund
+137%
HolleyHLLY
1.7% of the fund
+3%
Sagimet BiosciencesSGMT
1.5% of the fund
+278%
Corvus PharmaceuticalsCRVS
1.4% of the fund
+12%
Compass TherapeuticsCMPX
1.2% of the fund
+23%
Palvella TherapeuticsPVLA
0.8% of the fund
+16%
Oric PharmaceuticalsORIC
0.7% of the fund
+167%
LENZ TherapeuticsLENZ
0.7% of the fund
+49%
Starwood Property TrustSTWD
0.5% of the fund
+24%
EvommuneEVMN
0.4% of the fund
+80%

Cut

Sold some of their stake.

Aktis OncologyAKTS
15.0% of the fund
-3%
Cullinan TherapeuticsCGEM
4.3% of the fund
-19%
MapLight TherapeuticsMPLT
4.0% of the fund
-27%
EyePointEYPT
1.7% of the fund
-16%
Ultragenyx PharmaceuticalRARE
0.9% of the fund
-40%
ImageneBioIMA
0.8% of the fund
-4%
Immix BiopharmaIMMX
0.7% of the fund
-20%
Aquestive TherapeuticsAQST
0.6% of the fund
-30%
Eledon PharmaceuticalsELDN
0.3% of the fund
-60%
Context TherapeuticsCNTX
0.2% of the fund
-42%
WW InternationalWW
0.2% of the fund
-12%
Niocorp DevsNIOBW
<0.1% of the fund
-16%
Brand Engagement NetworkBNAIW
<0.1% of the fund
-13%

Sold out

Sold their entire stake.

Engene Holdings
-100%
Compass Pathways
-100%
CiveoCVEO
-100%
Kalvista Pharmaceuticals
-100%
Ovid TherapeuticsOVID
-100%
Pliant TherapeuticsPLRX
-100%
Larimar Therapeutics
-100%
Engene HoldingsENGNW
-100%
Enterprise Products Partners L.P.EPD
-100%
Syntec Optics HldgsOPTXW
-100%
Mineralys Therapeutics
-100%
Compass Therapeutics
-100%
Cardinal HealthCAH
-100%
Alpha Modus Hldgs INC CL A New
-100%
CID HoldcoDAIC
-100%
Vodafone Group
-100%
Viking Therapeutics
-100%
Gohealth
-100%
Structure Therapeutics
-100%
Olema Pharmaceuticals
-100%
Bitcoin DepotBTMWQ
-100%
Katapult HoldingsKPLTW
-100%

Holdings

Space Exploration TechnologiesSPCX
Share
36.3%
Value
$239m
Shares
1,398,815
New
Aktis OncologyAKTS
Share
15.0%
Value
$99m
Shares
3,070,219
-3%
Cullinan TherapeuticsCGEM
Share
4.3%
Value
$28m
Shares
1,539,764
-19%
Larimar TherapeuticsLRMR
Share
4.2%
Value
$28m
Shares
9,163,157
+29%
Nuveen Churchill Direct LendingNCDL
Share
4.0%
Value
$27m
Shares
2,143,626
Held
MapLight TherapeuticsMPLT
Share
4.0%
Value
$26m
Shares
729,929
-27%
Capital One FinancialCOF
Share
3.7%
Value
$24m
Shares
119,757
New
Blue Owl CapitalOBDC
Share
3.4%
Value
$22m
Shares
2,045,070
Held
Deep FissionFISN
Share
2.2%
Value
$15m
Shares
1,333,333
New
Dell TechnologiesDELL
Share
2.2%
Value
$14m
Shares
32,961
+137%
HolleyHLLY
Share
1.7%
Value
$11m
Shares
4,376,888
+3%
EyePointEYPT
Share
1.7%
Value
$11m
Shares
762,594
-16%
Sagimet BiosciencesSGMT
Share
1.5%
Value
$10m
Shares
1,260,544
+278%
Corvus PharmaceuticalsCRVS
Share
1.4%
Value
$9m
Shares
608,600
+12%
Artiva BiotherapeuticsARTV
Share
1.3%
Value
$8m
Shares
874,542
New
Compass TherapeuticsCMPX
Share
1.2%
Value
$8m
Shares
3,624,076
+23%
ConduentCNDT
Share
1.1%
Value
$7m
Shares
5,036,595
Held
Rhythm PharmaceuticalsRYTM
Share
1.0%
Value
$7m
Shares
61,455
Held
COMPASS PathwaysCMPS
Share
1.0%
Value
$6m
Shares
450,000
New
Ultragenyx PharmaceuticalRARE
Share
0.9%
Value
$6m
Shares
182,638
-40%
Palvella TherapeuticsPVLA
Share
0.8%
Value
$6m
Shares
36,259
+16%
ImageneBioIMA
Share
0.8%
Value
$5m
Shares
917,692
-4%
Viridian TherapeuticsVRDN
Share
0.7%
Value
$5m
Shares
260,000
New
Immix BiopharmaIMMX
Share
0.7%
Value
$5m
Shares
437,552
-20%
Oric PharmaceuticalsORIC
Share
0.7%
Value
$4m
Shares
400,000
+167%
LENZ TherapeuticsLENZ
Share
0.7%
Value
$4m
Shares
756,722
+49%
Aquestive TherapeuticsAQST
Share
0.6%
Value
$4m
Shares
942,932
-30%
Starwood Property TrustSTWD
Share
0.5%
Value
$3m
Shares
196,355
+24%
EvommuneEVMN
Share
0.4%
Value
$2m
Shares
180,000
+80%
Eledon PharmaceuticalsELDN
Share
0.3%
Value
$2m
Shares
566,509
-60%
Cabaletta BioCABA
Share
0.3%
Value
$2m
Shares
714,710
New
Chime FinancialCHYM
Share
0.3%
Value
$2m
Shares
89,878
New
Context TherapeuticsCNTX
Share
0.2%
Value
$2m
Shares
2,934,015
-42%
WW InternationalWW
Share
0.2%
Value
$1m
Shares
84,399
-12%
Marker TherapeuticsMRKR
Share
0.1%
Value
$814,748
Shares
554,250
Held
ADC Therapeutics SAADCT
Share
0.1%
Value
$784,918
Shares
733,568
Held
Helus PharmaHELP
Share
<0.1%
Value
$396,012
Shares
59,911
New
Fold HoldingsFLD
Share
<0.1%
Value
$385,484
Shares
856,632
Held
Niocorp DevsNIOBW
Share
<0.1%
Value
$380,958
Shares
268,280
-16%
Rezolve AIRZLVW
Share
<0.1%
Value
$213,960
Shares
235,121
Held
Brand Engagement NetworkBNAIW
Share
<0.1%
Value
$203,533
Shares
1,453,808
-13%
Piper Sandler CompaniesPIPR
Share
<0.1%
Value
$175,642
Shares
2,428
Held
Engene TherapeuticsENGNW
Share
<0.1%
Value
$148,190
Shares
511,177
New
CelcuityCELC
Share
<0.1%
Value
$130,670
Shares
1,249
New
StablecoinxUSDEW
Share
<0.1%
Value
$102,500
Shares
250,000
New
Energy Transfer L PET
Share
<0.1%
Value
$101,833
Shares
5,326
Held
Caris Life SciencesCAI
Share
<0.1%
Value
$83,950
Shares
4,711
Held
Vodafone GroupVOD
Share
<0.1%
Value
$71,005
Shares
5,371
New
DaveDAVEW
Share
<0.1%
Value
$68,425
Shares
28,750
Held
Murano Global InvestmentsMRNO
Share
<0.1%
Value
$62,850
Shares
261,875
New
Alpha Modus HldgsAMODW
Share
<0.1%
Value
$55,640
Shares
1,854,665
Held
RoadzenRDZNW
Share
<0.1%
Value
$42,750
Shares
225,000
Held
Alpha Modus HoldingsAMOD
Share
<0.1%
Value
$41,974
Shares
9,853
New
AEON BiopharmaAEON
Share
<0.1%
Value
$30,494
Shares
42,353
Held
Southland HldgsSLND-WS
Share
<0.1%
Value
$25,809
Shares
860,302
Held
Blue GoldBGLWW
Share
<0.1%
Value
$21,000
Shares
175,000
Held
SHF HoldingsSHFS
Share
<0.1%
Value
$18,215
Shares
75,897
Held
Blacksky TechnologyBKSYW
Share
<0.1%
Value
$17,500
Shares
350,000
Held
Tevogen BIO HldgsTVGNW
Share
<0.1%
Value
$12,000
Shares
200,000
Held
ZEO EnergyZEOWW
Share
<0.1%
Value
$10,000
Shares
250,000
New
Livewire GroupLVWR-WS
Share
<0.1%
Value
$8,000
Shares
400,000
New
Nvni Group LimitedNVNIW
Share
<0.1%
Value
$6,000
Shares
200,000
New
Katapult HoldingsKPLT
Share
<0.1%
Value
$5,373
Shares
5,421
Held
CID HoldcoDAICW
Share
<0.1%
Value
$4,445
Shares
444,515
Held
Baird MED Invt HldgsBDMDW
Share
<0.1%
Value
$4,000
Shares
100,000
Held
Pagaya TechnologiesPGYWW
Share
<0.1%
Value
$2,433
Shares
48,661
Held
Stardust PWRSDSTW
Share
<0.1%
Value
$2,167
Shares
16,666
Held
Liminatus PharmaLIMNW
Share
<0.1%
Value
$2,000
Shares
50,000
Held
WaldencastWALDW
Share
<0.1%
Value
$1,667
Shares
33,333
Held
XBP Global HoldingsXBPEW
Share
<0.1%
Value
$1,487
Shares
24,778
Held
Aspire Biopharma HldgsASBPW
Share
<0.1%
Value
$1,000
Shares
50,000
Held

Company	Share of fund	Value	Shares	Change
Space Exploration TechnologiesSPCX	36.3%	$239m	1,398,815	New
Aktis OncologyAKTS	15.0%	$99m	3,070,219	-3%
Cullinan TherapeuticsCGEM	4.3%	$28m	1,539,764	-19%
Larimar TherapeuticsLRMR	4.2%	$28m	9,163,157	+29%
Nuveen Churchill Direct LendingNCDL	4.0%	$27m	2,143,626	Held
MapLight TherapeuticsMPLT	4.0%	$26m	729,929	-27%
Capital One FinancialCOF	3.7%	$24m	119,757	New
Blue Owl CapitalOBDC	3.4%	$22m	2,045,070	Held
Deep FissionFISN	2.2%	$15m	1,333,333	New
Dell TechnologiesDELL	2.2%	$14m	32,961	+137%
HolleyHLLY	1.7%	$11m	4,376,888	+3%
EyePointEYPT	1.7%	$11m	762,594	-16%
Sagimet BiosciencesSGMT	1.5%	$10m	1,260,544	+278%
Corvus PharmaceuticalsCRVS	1.4%	$9m	608,600	+12%
Artiva BiotherapeuticsARTV	1.3%	$8m	874,542	New
Compass TherapeuticsCMPX	1.2%	$8m	3,624,076	+23%
ConduentCNDT	1.1%	$7m	5,036,595	Held
Rhythm PharmaceuticalsRYTM	1.0%	$7m	61,455	Held
COMPASS PathwaysCMPS	1.0%	$6m	450,000	New
Ultragenyx PharmaceuticalRARE	0.9%	$6m	182,638	-40%
Palvella TherapeuticsPVLA	0.8%	$6m	36,259	+16%
ImageneBioIMA	0.8%	$5m	917,692	-4%
Viridian TherapeuticsVRDN	0.7%	$5m	260,000	New
Immix BiopharmaIMMX	0.7%	$5m	437,552	-20%
Oric PharmaceuticalsORIC	0.7%	$4m	400,000	+167%
LENZ TherapeuticsLENZ	0.7%	$4m	756,722	+49%
Aquestive TherapeuticsAQST	0.6%	$4m	942,932	-30%
Starwood Property TrustSTWD	0.5%	$3m	196,355	+24%
EvommuneEVMN	0.4%	$2m	180,000	+80%
Eledon PharmaceuticalsELDN	0.3%	$2m	566,509	-60%
Cabaletta BioCABA	0.3%	$2m	714,710	New
Chime FinancialCHYM	0.3%	$2m	89,878	New
Context TherapeuticsCNTX	0.2%	$2m	2,934,015	-42%
WW InternationalWW	0.2%	$1m	84,399	-12%
Marker TherapeuticsMRKR	0.1%	$814,748	554,250	Held
ADC Therapeutics SAADCT	0.1%	$784,918	733,568	Held
Helus PharmaHELP	<0.1%	$396,012	59,911	New
Fold HoldingsFLD	<0.1%	$385,484	856,632	Held
Niocorp DevsNIOBW	<0.1%	$380,958	268,280	-16%
Rezolve AIRZLVW	<0.1%	$213,960	235,121	Held
Brand Engagement NetworkBNAIW	<0.1%	$203,533	1,453,808	-13%
Piper Sandler CompaniesPIPR	<0.1%	$175,642	2,428	Held
Engene TherapeuticsENGNW	<0.1%	$148,190	511,177	New
CelcuityCELC	<0.1%	$130,670	1,249	New
StablecoinxUSDEW	<0.1%	$102,500	250,000	New
Energy Transfer L PET	<0.1%	$101,833	5,326	Held
Caris Life SciencesCAI	<0.1%	$83,950	4,711	Held
Vodafone GroupVOD	<0.1%	$71,005	5,371	New
DaveDAVEW	<0.1%	$68,425	28,750	Held
Murano Global InvestmentsMRNO	<0.1%	$62,850	261,875	New
Alpha Modus HldgsAMODW	<0.1%	$55,640	1,854,665	Held
RoadzenRDZNW	<0.1%	$42,750	225,000	Held
Alpha Modus HoldingsAMOD	<0.1%	$41,974	9,853	New
AEON BiopharmaAEON	<0.1%	$30,494	42,353	Held
Southland HldgsSLND-WS	<0.1%	$25,809	860,302	Held
Blue GoldBGLWW	<0.1%	$21,000	175,000	Held
SHF HoldingsSHFS	<0.1%	$18,215	75,897	Held
Blacksky TechnologyBKSYW	<0.1%	$17,500	350,000	Held
Tevogen BIO HldgsTVGNW	<0.1%	$12,000	200,000	Held
ZEO EnergyZEOWW	<0.1%	$10,000	250,000	New
Livewire GroupLVWR-WS	<0.1%	$8,000	400,000	New
Nvni Group LimitedNVNIW	<0.1%	$6,000	200,000	New
Katapult HoldingsKPLT	<0.1%	$5,373	5,421	Held
CID HoldcoDAICW	<0.1%	$4,445	444,515	Held
Baird MED Invt HldgsBDMDW	<0.1%	$4,000	100,000	Held
Pagaya TechnologiesPGYWW	<0.1%	$2,433	48,661	Held
Stardust PWRSDSTW	<0.1%	$2,167	16,666	Held
Liminatus PharmaLIMNW	<0.1%	$2,000	50,000	Held
WaldencastWALDW	<0.1%	$1,667	33,333	Held
XBP Global HoldingsXBPEW	<0.1%	$1,487	24,778	Held
Aspire Biopharma HldgsASBPW	<0.1%	$1,000	50,000	Held

Options (5)

Compass Pathways
Type
Call
Value
$5m
Contracts
1,670,500
Erasca
Type
Call
Value
$795,000
Contracts
100,000
Eledon Pharmaceuticals
Type
Call
Value
$285,000
Contracts
200,000
Larimar Therapeutics
Type
Call
Value
$145,720
Contracts
728,600
Compass Therapeutics
Type
Call
Value
$106,330
Contracts
303,800

Company	Type	Value	Contracts
Compass Pathways	Call	$5m	1,670,500
Erasca	Call	$795,000	100,000
Eledon Pharmaceuticals	Call	$285,000	200,000
Larimar Therapeutics	Call	$145,720	728,600
Compass Therapeutics	Call	$106,330	303,800

Over time and by industry

Value over time

Jun '25

Dec '25

Jun '26

Value is up 112.4% since 30 June 2025.

Where the money is

Health care44.1%

Technology39.6%

Financial services4.5%

Utilities2.2%

Retail & consumer1.9%

Other7.7%

From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.